Clinical Trial Update: Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD [Phase 4]

View source ↗

Summary

This is a status update on a Phase 4 clinical trial evaluating oral calcitriol to reduce mild proteinuria in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Proteinuria

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

Sponsor: Huashan Hospital | Conditions: Chronic Kidney Disease, Proteinuria | Phase 4 | Status: UNKNOWN